维普中文期刊产品整合服务
76篇 您的检索式:作者名="CALLS I"
    题名 作者 年代 出处 被引量
1Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort显示文摘BACKGROUND Colorectal cancer(CRC) is the second most common cause of cancer death worldwide. It is broadly described that cyclooxygenase-2(COX-2) is mainly overexpressed in CRC but less is known regarding post-translational modifications of this enzyme that may regulate its activity, intracellular localization and stability. Since metabolic and proteomic profile analysis is essential for cancer prognosis and diagnosis, our hypothesis is that the analysis of correlations between these specific parameters and COX-2 state in tumors of a high number of CRC patients could be useful for the understanding of the basis of this cancer in humans.AIM To analyze COX-2 regulation in colorectal cancer and to perform a detailed analysis of their metabolic and proteomic profile.METHODS Biopsies from both healthy and pathological colorectal tissues were taken under informed consent from patients during standard colonoscopy procedure in the University Hospital of Bellvitge(Barcelona, Spain) and Germans Trias i Pujol University Hospital(Campus Can Ruti)(Barcelona, Spain). Western blot analysis was used to determine COX-2 levels. Deglycosylation assays were performed in both cells and tumor samples incubating each sample with peptide N-glycosidase F(PNGase F). Prostaglandin E2(PGE2) levels were determined using a specific ELISA. 1 H high resolution magic angle spinning(HRMAS) analysis was performed using a Bruker AVIII 500 MHz spectrometer and proteomic analysis was performed in a nano-liquid chromatography-tandem mass spectrometer(nano LC-MS/MS) using a QExactive HF orbitrap MS.RESULTS Our data show that COX-2 has a differential expression profile in tumor tissue of CRC patients vs the adjacent non-tumor area, which correspond to a glycosylated and less active state of the protein. This fact was associated to a lesser PGE2 production in tumors. These results were corroborated in vitro performing deglycosylation assays in HT29 cell line where COX-2 protein profile was modified after PNGase F incubation, showing higher PGE2 levels. Moreover,HRMAS analysis indicated that tumor tissue has altered metabolic features vs non-tumor counterparts, presenting increased levels of certain metabolites such as taurine and phosphocholine and lower levels of lactate. In proteomic experiments, we detected an enlarged number of proteins in tumors that are mainly implicated in basic biological functions like mitochondrial activity,DNA/RNA processing, vesicular trafficking, metabolism, cytoskeleton and splicing.CONCLUSION In our colorectal cancer cohort, tumor tissue presents a differential COX-2 expression pattern with lower enzymatic activity that can be related to an altered metabolic and proteomic profile.Patricia Prieto Rafael I Jaén Daniel Calle María Gómez-Serrano Estefanía Nú?ez María Fernández-Velasco Paloma Martín-Sanz Sergio Alonso Jesús Vázquez Sebastián Cerdán Miguel ángel Peinado Lisardo Boscá 2019World Journal of Gastroenterology2019,25,4:4
2Endoscopic ultrasound-guided through-the-needle microforceps biopsy and needle-based confocal laser-endomicroscopy increase detection of potentially malignant pancreatic cystic lesions:A single-center study显示文摘BACKGROUND Currently,there is insufficient data about the accuracy in the diagnosing of pancreatic cystic lesions(PCLs),especially with novel endoscopic techniques such as with direct intracystic micro-forceps biopsy(mFB)and needle-based confocal laser-endomicroscopy(nCLE).AIM To compare the accuracy of endoscopic ultrasound(EUS)and associated techniques for the detection of potentially malignant PCLs:EUS-guided fine needle aspiration(EUS-FNA),contrast-enhanced EUS(CE-EUS),EUS-guided fiberoptic probe cystoscopy(cystoscopy),mFB,and nCLE.METHODS This was a single-center,retrospective study.We identified patients who had undergone EUS,with or without additional diagnostic techniques,and had been diagnosed with PCLs.We determined agreement among malignancy after 24-mo follow-up findings with detection of potentially malignant PCLs via the EUSguided techniques and/or EUS-guided biopsy when available(EUS malignancy detection).RESULTS A total of 129 patients were included, with EUS performed alone in 47/129. In 82/129 patients,EUS procedures were performed with additional EUS-FNA (21/82), CE-EUS (20/82), cystoscopy(27/82), mFB (36/82), nCLE (44/82). Agreement between EUS malignancy detection and the 24-mo follow-up findings was higher when associated with additional diagnostic techniques thanEUS alone [62/82 (75.6%) vs 8/47 (17%);OR 4.35, 95%CI: 2.70-7.37;P < 0.001]. The highestmalignancy detection accuracy was reached when nCLE and direct intracystic mFB were bothperformed, with a sensitivity, specificity, positive predictive value, negative predictive value andobserved agreement of 100%, 89.4%, 77.8%, 100% and 92.3%, respectively (P < 0.001 comparedwith EUS-alone).CONCLUSIONThe combined use of EUS-guided mFB and nCLE improves detection of potentially malignantPCLs compared with EUS-alone, EUS-FNA, CE-EUS or cystoscopy.Carlos Robles-Medranda Juan I Olmos Miguel Puga-Tejada Roberto Oleas Jorge Baquerizo-Burgos Martha Arevalo-Mora Raquel Del Valle Zavala Joao Autran Nebel Daniel Calle Loffredo Hannah Pitanga-Lukashok 2022World Journal of Gastrointestinal Endoscopy2022,14,3:2
3Secoiridoid glucosides from Lonicera periclymenum显示文摘CALLS I STICHER O 1984Phytochemistry1984,23,11:1
4(6S)- Hydroxy - 3- oxo- a- ionol glucosides from Capparis spinosa fruits 显示文摘CALLS I KURUUZUM A LORENZETTO P A 2002Phytochemistry2002,59,4:1
53-MCPD in food other than soy sauce or hydrolysed vegetable protein (HVP) 显示文摘BAER I DE LA CALLE B TAYLOR P 2010Anal Bioanal Chem2010,396,1:1
6History, Overview and Application of Mediated Lignolytic System 显示文摘Call P Mucke I 1997J Biotech1997,53,:1
7The ocular ischemic syndrome 显示文摘Foncea Beti N Mateo I Diaz La Calle V 2003Clin Neurol Neurosurg2003,106,1:1
8overview and applications of mediated lignolytic systems, especially laccase-mediator-systems (lignozymprocess) 显示文摘Call H P Mticke I History 1997J Biotechnol1997,53,:1
9History,overviewand applications of mediated lignolytic systems,especially laccase-mediator-systems (Lignozym(R)-process)显示文摘H P Call I Mucke 1997J Biotechnol1997,53,:1
103-MCPD in food other than soy sauce or hydrolysed vegetable protein (HVP) 显示文摘Baer I De La Calle B Taylor P 2010Analytical and Bioanalytical Chemistry2010,396,1:1
11The ocular ischemic syndrome显示文摘Foncea Beti N Mateo I Diaz La Calle V 2003Clin Neurol Neurosurg2003,106,:1
12Discrete element modeling(DEM) of triboelectricaUy charged particles: revised experiments显示文摘HOGUE M D CALLE C I CURRY D R 2009Journal of Electrostatics2009,67,4:1
13Evaluation of the BD ProbeTec ET system as screening tool in the direct detection of mycobacterium tuberculosis complex in respiratory specimens显示文摘Jesús de la calle I Jesús de la calle MA Rodríguez-Iglesias M 2003Diagn Microbiol Infect Dis2003,47,4:1
143-MCPD in food other than soy sauce or hydrolysed vegetable protein (HVP)显示文摘BAER I CALLE B D L TAYLOR P 2010Anal Bioanal Chem2010,396,:1
15Diabetes mellitus as a hypercoagulable state: its relation with fibrin fragments and vascular damage显示文摘Garcia Frade L J Calle H Alava I 1987Thromb Res1987,,47:1
16Clinical phenotypes of COPD : identification, definition and implications for guidelines显示文摘Miravitlles M Calle M Soler-Catalu i a JJ 2012Archivos de Bronconeumologia ( English Edition )2012,48,3:1
17Discography in degenerating disc disease显示文摘Fraser J Mc Call I Park W 1983Orthop Trans1983,7,3:1
18A new approach to grading and treating COPD based on clinical phenotypes : summary of the Spanish COPD guidelines (GesEPOC) 显示文摘Miravitlles M Soler-Catalu i a JJ Calle M 2013Prim Care Respir J2013,22,1:1
19Discography in degenerating disc disease显示文摘Fraser J Mc Call I Park W 1983Orthop Trans1983,7,3:1
20Neolignan, flavonoid, phe- nylethanoid and iridoid glycosides from Phlomis integrifolia 显示文摘Saracoglu I Varel M Calls I 2003Turk J Chero2003,27,6:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费